Mississippi Psychedelic Legislation

8 psychedelic policy bills tracked in Mississippi, covering Ibogaine, Psilocybin. Current status breakdown: Died (6), Signed into Law (2).

Mississippi psychedelic bills

Bill	State	Substance	Type	Status	Sponsor	Last action
HB314 - Ibogaine; authorize SDH to select a consortium to conduct a drug development clinical trial with, to secure FDA's approval of.	Mississippi	Ibogaine	Clinical Research	Signed into Law	Sam Creekmore	Mar 26, 2026
SB2056 - Controlled substances; provide for automatic scheduling of certain substance if federal scheduling occurs.	Mississippi	Psilocybin	Scheduling	Signed into Law	Angela Turner-Ford	Mar 13, 2026
HB563 - Controlled substances; provide for automatic scheduling of psilocybin after federal scheduling.	Mississippi	Psilocybin	Scheduling	Died	Sam Creekmore	Mar 11, 2026
HB1803 - Appropriation; MDA to provide funding to Alcorn State for expansion of research and production of shiitake mushrooms.	Mississippi	Psilocybin	Clinical Research	Died	Jeffery Harness	Feb 25, 2026
SB2561 - Ibogaine; authorize MSDH to select a consortium to conduct a drug development clinical trial to secure FDA's approval of.	Mississippi	Ibogaine	Clinical Research	Died	Josh Harkins	Feb 3, 2026
SB2562 - Mississippi Veterans PTSD Ibogaine Research Pilot Program; create.	Mississippi	Ibogaine	Scheduling	Died	Jeff Tate	Feb 3, 2026
HB1792 - Appropriation; MDA to provide funding to Alcorn State for expansion of research and production of shiitake mushrooms.	Mississippi	Psilocybin	Clinical Research	Died	Jeffery Harness	Feb 26, 2025
HB703 - Appropriation; MDA to provide funding to Alcorn State for expansion of research and production of shiitake mushrooms.	Mississippi	Psilocybin	Clinical Research	Died	Jeffery Harness	Mar 27, 2024

All states · Full psychedelic legislation tracker